Related Experiment Videos
Pseudomyxoma peritonei--experience from a tertiary referral centre
1Department of Obstetrics and Gynecology, Women's Cancer Center, University of Minnesota, Minneapolis.
Summary
Pseudomyxoma peritonei causes abdominal swelling from gelatinous material, often from ovarian or appendiceal tumors. This rare condition, though histologically benign, behaves aggressively, requiring surgical debulking for intestinal obstruction relief.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Pseudomyxoma peritonei is a rare condition characterized by gelatinous ascites.
- It typically originates from appendiceal or ovarian mucinous neoplasms.
- The disease presents as massive abdominal distension due to tumor spread within the peritoneal cavity.
Purpose of the Study:
- To describe the clinical diagnosis, behavior, and treatment challenges of pseudomyxoma peritonei.
- To highlight the discrepancy between histological benignity and clinical malignancy.
- To review the efficacy of various adjuvant therapies.
Main Methods:
- Clinical case review and literature synthesis.
- Histopathological analysis of pseudomyxoma peritonei.
- Evaluation of treatment outcomes for surgical debulking and adjuvant therapies.
Main Results:
- Pseudomyxoma peritonei is characterized by recurrent growth within the peritoneum, causing intestinal obstruction.
- Histologically, the tumors are often benign but exhibit malignant clinical behavior without stromal invasion.
- Adjuvant treatments including chemotherapy, radiotherapy, and immunotherapy have shown variable and unreproducible responses.
Conclusions:
- Pseudomyxoma peritonei necessitates surgical debulking to manage intestinal obstruction.
- There is currently no universally accepted or consistently effective adjuvant treatment for pseudomyxoma peritonei.
- Further research is needed to identify reproducible and effective adjuvant therapies.